A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease

Wiener Klinische Wochenschrift

Volumn 119, Issue 17-18, 2007, Pages 519-526

  Teml, Alexander ^a,b,c   Schwab, Matthias ^b,c   Hommes, Daan W ^d   Almer, Sven ^e   Lukas, Milan ^f   Feichtenschlager, Thomas ^g   Florin, Timothy ^h   Seiderer, Julia ⁱ   Petritsch, Wolfgang ^j   Bokemeyer, Bernd ^k   Kreisel, Wolfgang ^l   Herrlinger, Klaus R ^m   Knoflach, Peter ⁿ   Bonaz, Bruno ^o   Klugmann, Thomas ^p   Herfarth, Hans ^q   Pedarnig, Nikolaus ^r   Reinisch, Walter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LINKÖPING UNIVERSITY   (Sweden)

^f CHARLES UNIVERSITY   (Czech Republic)

^g KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^h MATER HOSPITAL   (Australia)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^j MEDICAL UNIVERSITY OF GRAZ   (Austria)

^k Medical University of Graz ^*  (Germany)

^l UNIVERSITY OF FREIBURG   (Germany)

^m ROBERT BOSCH HOSPITAL   (Germany)

ⁿ Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^o GRENOBLE UNIVERSITY HOSPITAL   (France)

^p Internistische Gemeinschaftspraxis   (Germany)

^q UNIVERSITY OF REGENSBURG   (Germany)

^r Unidata Geodesign   (Austria)

more..

Author keywords

6 thioguanine; Drug induced liver injury; Inflammatory bowel disease; Nodular regenerative hyperplasia; Thiopurines

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; METHOTREXATE; TIOGUANINE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLEEDING; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG INDUCED HEADACHE; ECHOGRAPHY; ENTERITIS; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HAIR LOSS; HEALTH SURVEY; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; INFECTION; LABORATORY TEST; LEUKOPENIA; LIVER BIOPSY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NAUSEA AND VOMITING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONLINE ANALYSIS; PAIN; PERICARDITIS; PREVALENCE; REVIEW; RISK FACTOR; SCHOOL CHILD; SIDE EFFECT; SKIN TOXICITY; STOMATITIS; THROMBOCYTOPENIA; TREATMENT DURATION; UREA BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHILD; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERNET; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SMOKING; THIOGUANINE; TREATMENT OUTCOME;

EID: 35548984962     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0841-0     Document Type: Review

References (42)

1. Harms DO, Janka-Schaub GE (2000) Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia 14: 2234-2239
2. Ravindranath Y, Chang M, Steuber CP, Becton D, Dahl G, Civin C, et al (2005) Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 19: 2101-2116
3. Mason C, Krueger GG (2001) Thioguanine for refractory psoriasis: a 4-year experience. J Am Acad Dermatol 44: 67-72
4. Dubinsky MC, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, et al (2001) An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy. Inflamm Bowel Dis 7: 181-189
5. Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, et al (2003) 6-thioguanine - efficacy and safety in chronic active Crohn's disease. Aliment Pharmacol Ther 17: 503-508
6. Herrlinger KR, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, et al (2003) Remission maintenance by tioguanine in chronic active Crohn's disease. Aliment Pharmacol Ther 17: 1459-1464
7. Deibert P, Dilger K, Fischer C, Hofmann U, Nauck S, Stoelben S, et al (2003) High variation of tioguanine absorption in patients with chronic active Crohn's disease. Aliment Pharmacol Ther 18: 183-189
8. Bonaz B, Boitard J, Marteau P, Lemann M, Coffin B, Flourie B, et al (2003) Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Aliment Pharmacol Ther 18: 401-408
9. Derijks LJ, de Jong DJ, Gilissen LP, Engels LG, Hooymans PM, Jansen JB, et al (2003) 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment. Eur J Gastroenterol Hepatol 15: 63-67
10. Dubinsky MC, Feldman EJ, Abreu MT, Targan SR, Vasiliauskas EA (2003) Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine. Am J Gastroenterol 98: 1058-1063
11. Cheung TK, Florin TH (2003) 6-thioguanine: a new old drug to procure remission in inflammatory bowel disease. Intern Med J 33: 44-46
12. Teml A, Schwab M, Harrer M, Miehsler W, Schaeffeler E, Dejaco C, et al (2005) A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis. Scand J Gastroenterol 40: 1205-1213
13. de Boer NK, Derijks LJ, Gilissen LP, Hommes DW, Engels LG, de-Boer SY, et al (2005) On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients. World J Gastroenterol 11: 5540-5544
14. Griner PF, Elbadawi A, Packman CH (1976) Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases. Ann Intern Med 85: 578-582
15. Gill RA, Onstad GR, Cardamone JM, Maneval DC, Sumner HW (1982) Hepatic veno-occlusive disease caused by 6-thioguanine. Ann Intern Med 96: 58-60
16. Krivoy N, Raz R, Carter A, Alroy G (1982) Reversible hepatic veno-occlusive disease and 6-thioguanine. Ann Intern Med 96: 788
17. Stoneham S, Lennard L, Coen P, Lilleyman J, Saha V (2003) Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia. Br J Haematol 123: 100-102
18. Key NS, Kelly PM, Emerson PM, Chapman RW, Allan NC, McGee JO (1987) Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia. Lancet 2: 1050-1052
19. Dubinsky MC, Vasiliauskas EA, Singh H, Abreu MT, Papadakis KA, Tran T, et al (2003) 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 125: 298-303
20. Seiderer J, Zech CJ, Reinisch W, Lukas M, Diebold J, Wrba F, et al (2005) A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. J Hepatol 43: 303-309
21. Geller SA, Dubinsky MC, Poordad FF, Vasiliauskas EA, Cohen AH, Abreu MT, et al (2004) Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease. Am J Surg Pathol 28: 1204-1211
22. Gilissen LP, Derijks LJ, Driessen A, Bos LP, Hooymans PM, Stockbrugger RW, et al (2007) Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects? Dig Liver Dis 39: 156-159
23. Piel B, Vaidya S, Lancaster D, Taj M, Pritchard-Jones K (2004) Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia. Br J Haematol 125: 410-411
24. De Bruyne R, Portmann B, Samyn M, Bansal S, Knisely A, Mieli-Vergani G, et al (2006) Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. J Hepatol 44: 407-410
25. de Boer NK, Reinisch W, Teml A, van Bodegraven AA, Schwab M, Lukas M, et al (2006) 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party. Digestion 73: 25-31
26. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207-214
27. Reshamwala PA, Kleiner DE, Heller T (2006) Nodular regenerative hyperplasia: Not all nodules are created equal. Hepatology 44: 7-14
28. Kuchenbecker J, Dick HB, Schmitz K, Behrens-Baumann W (2001) Use of internet technologies for data acquisition in large clinical trials. Telemed J E Health 7: 73-76
29. Lindh JD, Kublickas M, Westgren M, Rane A (2004) Internet based clinical trial protocols - as applied to a study of warfarin pharmacogenetics. Br J Clin Pharmacol 58: 482-487
30. de Boer NK, Gilissen LP, Derijks LJ, den Hartog G, Westerveld BD, Engels LG, et al (2006) Hepatotoxicity of long-term and low-dose 6-thioguanine in IBD patients. Gastroenterology 130: A-202-203
31. Derijks LJ, Gilissen LP, de Boer NK, Mulder CJ (2006) 6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: dose or level dependent? J Hepatol 44: 821-822
32. de Boer NK, de GP, Wilhelm AJ, Mulder CJ, van Bodegraven AA (2005) On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment. Aliment Pharmacol Ther 22: 447-451
33. Derijks LJ, Gilissen LP, Engels LG, Bos LP, Bus PJ, Lohman JJ, et al (2006) Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease. Ther Drug Monit 28: 45-50
34. Lancaster DL, Lennard L, Rowland K, Vora AJ, Lilleyman JS (1998) Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations. Br J Haematol 102: 439-443
35. Herrlinger KR, Fellermann K, Fischer C, Kreisel W, Deibert P, Schoelmerich J, et al (2004) Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease. Aliment Pharmacol Ther 19: 1269-1276
36. Duley JA, Florin TH (2005) Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides. Ther Drug Monit 27: 647-654
37. Khalil PN, Erb N, Khalil MN, Escherich G, Janka-Schaub GE (2006) Validation and application of a high-performance liquid chromatographic-based assay for determination of the inosine 5′-monophosphate dehydrogenase activity in erythrocytes. J Chromatogr B Analyt Technol Biomed Life Sci 842: 1-7
38. Daniel F, Cadranel JF, Seksik P, Cazier A, Duong Van Huyen JP, Ziol M, et al (2005) Azathioprine induced nodular regenerative hyperplasia in IBD patients. Gastroenterol Clin Biol 29: 600-603
39. Chatelain D, Van Damme H, Brazier F, Geslin G, Bartoli E, Khac EN, et al (2005) High 6-thioguanine nucleotide (6-TGN) levels after azathioprine treatment are not associated with increased risk for serious hepatic damage. Gastroenterology 128: A-305-306
40. Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, et al (2007) Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut: May 15 (epub ahead of print)
41. Wanless IR (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11: 787-797
42. Zech CJ, Seiderer J, Reinisch W, Ochsenkuhn T, Schima W, Diebold J, et al (2007) Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques. Eur Radiol 17: 1898-1905